Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

More articles from BEHAVIORAL PHARMACOLOGY

  • You have access
    Cebranopadol Blocks the Escalation of Cocaine Intake and Conditioned Reinstatement of Cocaine Seeking in Rats
    Giordano de Guglielmo, Alessandra Matzeu, Jenni Kononoff, Julia Mattioni, Rémi Martin-Fardon and Olivier George
    Journal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 378-384; DOI: https://doi.org/10.1124/jpet.117.241042
  • You have access
    Cannabinoid CB2 Agonist GW405833 Suppresses Inflammatory and Neuropathic Pain through a CB1 Mechanism that is Independent of CB2 Receptors in Mice
    Ai-Ling Li, Lawrence M. Carey, Ken Mackie and Andrea G. Hohmann
    Journal of Pharmacology and Experimental Therapeutics August 2017, 362 (2) 296-305; DOI: https://doi.org/10.1124/jpet.117.241901
  • You have access
    Apparent Affinity Estimates and Reversal of the Effects of Synthetic Cannabinoids AM-2201, CP-47,497, JWH-122, and JWH-250 by Rimonabant in Rhesus Monkeys
    Lenka Hruba and Lance R. McMahon
    Journal of Pharmacology and Experimental Therapeutics August 2017, 362 (2) 278-286; DOI: https://doi.org/10.1124/jpet.117.240572
  • You have access
    TRV0109101, a G Protein-Biased Agonist of the µ-Opioid Receptor, Does Not Promote Opioid-Induced Mechanical Allodynia following Chronic Administration
    Michael Koblish, Richard Carr, Edward R. Siuda, David H. Rominger, William Gowen-MacDonald, Conrad L. Cowan, Aimee L. Crombie, Jonathan D. Violin and Michael W. Lark
    Journal of Pharmacology and Experimental Therapeutics August 2017, 362 (2) 254-262; DOI: https://doi.org/10.1124/jpet.117.241117
  • You have access
    Apparent CB1 Receptor Rimonabant Affinity Estimates: Combination with THC and Synthetic Cannabinoids in the Mouse In Vivo Triad Model
    T. W. Grim, A. J. Morales, B. F. Thomas, J. L. Wiley, G. W. Endres, S. S. Negus and A. H. Lichtman
    Journal of Pharmacology and Experimental Therapeutics July 2017, 362 (1) 210-218; DOI: https://doi.org/10.1124/jpet.117.240192
  • You have access
    Effects of Acute and Chronic Treatments with Dopamine D2 and D3 Receptor Ligands on Cocaine versus Food Choice in Rats
    Morgane Thomsen, Andrew C. Barrett, Paul Butler, S. Stevens Negus and S. Barak Caine
    Journal of Pharmacology and Experimental Therapeutics July 2017, 362 (1) 161-176; DOI: https://doi.org/10.1124/jpet.117.241141
  • You have access
    Preference for an Opioid/Benzodiazepine Mixture over an Opioid Alone Using a Concurrent Choice Procedure in Rhesus Monkeys
    Peter F. Weed, Charles P. France and Lisa R. Gerak
    Journal of Pharmacology and Experimental Therapeutics July 2017, 362 (1) 59-66; DOI: https://doi.org/10.1124/jpet.117.240200
  • You have access
    Relief of Pain-Depressed Behavior in Rats by Activation of D1-Like Dopamine Receptors
    Matthew F. Lazenka, Kelen C. Freitas, Sydney Henck and S. Stevens Negus
    Journal of Pharmacology and Experimental Therapeutics July 2017, 362 (1) 14-23; DOI: https://doi.org/10.1124/jpet.117.240796
  • You have access
    σ Receptor Effects of N-Substituted Benztropine Analogs: Implications for Antagonism of Cocaine Self-Administration
    Takato Hiranita, Weimin C. Hong, Theresa Kopajtic and Jonathan L. Katz
    Journal of Pharmacology and Experimental Therapeutics July 2017, 362 (1) 2-13; DOI: https://doi.org/10.1124/jpet.117.241109
  • You have access
    Propofol Anesthesia Is Reduced in Phospholipase C–Related Inactive Protein Type-1 Knockout Mice
    Yoshikazu Nikaido, Tomonori Furukawa, Shuji Shimoyama, Junko Yamada, Keisuke Migita, Kohei Koga, Tetsuya Kushikata, Kazuyoshi Hirota, Takashi Kanematsu, Masato Hirata and Shinya Ueno
    Journal of Pharmacology and Experimental Therapeutics June 2017, 361 (3) 367-374; DOI: https://doi.org/10.1124/jpet.116.239145

Pages

  • Previous
  • Next
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 64
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics